Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data
Open Access
- 3 April 2013
- journal article
- review article
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2013, 1-8
- https://doi.org/10.1155/2013/450639
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common, chronic liver disease worldwide. Within this spectrum, steatosis alone is apparently benign, while nonalcoholic steatohepatitis may progress to cirrhosis and hepatocellular carcinoma. NAFLD is strongly associated with obesity, dyslipidemia, type 2 diabetes mellitus, and cardiovascular disease. The pathogenesis of hepatic steatosis is not clearly known, but its main characteristics are considered insulin resistance, mitochondrial dysfunction, increased free fatty acids reflux from adipose tissue to the liver, hepatocyte lipotoxicity, stimulation of chronic necroinflammation, and fibrogenic response. With recent advances in technology, advanced imaging techniques provide important information for diagnosis. There is a significant research effort in developing noninvasive monitoring of disease progression to fibrosis and response to therapy with potential novel biomarkers, in order to facilitate diagnosis for the detection of advanced cirrhosis and to minimize the need of liver biopsy. The identification of NAFLD should be sought as part of the routine assessment of type 2 diabetics, as sought the microvascular complications and cardiovascular disease, because it is essential for the early diagnosis and proper intervention. Diet, exercise training, and weight loss provide significant clinical benefits and must be considered of first line for treating NAFLD.Keywords
This publication has 72 references indexed in Scilit:
- Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyVideosurgery and Other Miniinvasive Techniques, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2010
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced diseaseGut, 2008
- Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective studyInternational Journal of Clinical Practice, 2008
- Liver Fat Is Increased in Type 2 Diabetic Patients and Underestimated by Serum Alanine Aminotransferase Compared With Equally Obese Nondiabetic SubjectsDiabetes Care, 2008
- Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn StudyAtherosclerosis, 2007
- Nonalcoholic fatty liver disease is a novel predictor of cardiovascular diseaseWorld Journal of Gastroenterology, 2007
- Statins and hepatic steatosis: Perspectives from the Dallas Heart StudyJournal of Hepatology, 2006
- Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic PatientsDiabetes, 2005
- Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely ObeseGastroenterology, 2001